| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8837463 | Surgery | 2016 | 11 Pages |
Abstract
Addition of radiation to adjuvant chemotherapy after margin-negative resection of pancreatic adenocarcinoma is associated with a limited survival benefit in patients with pathologic stage IIB disease and should be weighed against its associated risks in these patient groups.
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
Olga MD, MS, Mark S. MD, Waseem BS, Chi-Hsiung PhD, David J. MD, Robert MD, Richard A. MD, Marshall S. MD, MBA, FACS,